Vaxine Pty Ltd - Adelaide, South Australia

+61 (0)420 878 911
queries@vaxine.net

Follow

Vaxine Vaxine
Skip to content
  • Home
  • About
    • About
    • People
  • Projects
  • Publications
  • News
  • Contact

Vaxine Pty Ltd - Adelaide, South Australia

+61 (0)420 878 911
queries@vaxine.net

Follow

Tag: Publication

vamtam-theme-circle-post
 Category Vaxine Updates

Recent paper on use of our ADVAX-CPG Adjuvant in Herpes Simplex virus vaccine development

September 17, 2021
This latest paper highlights a Herpes simplex virus vaccine being developed in collaboration with our...
 Tags ADVAX-CPG Adjuvant, Publication, Research
Read More
vamtam-theme-circle-post
 Category Vaxine Updates

Our modeling paper “In silico comparison of SARS-COV-2 spike protein-ace2 binding affinities across species and implications for virus origin” published in Nature Scientific Reports

June 25, 2021
Our Modeling paper on the origins of SARS-CoV-2 just got published by Nature Scientific Reports....
 Tags Publication, Research
Read More
https://vaxine.net/wp-content/uploads/2022/03/cropped-logo.png

Vaxine is an Australian-based biotechnology company that over the last 20 years has developed an extensive portfolio of vaccines and immunotherapies, including vaccines against Covid-19, influenza, hepatitis B, and Japanese encephalitis plus immunotherapies against allergy and cancer.  Underlying all these successful vaccines is Vaxine’s powerful vaccine adjuvant technology plus its capabilities in applying artificial intelligence to rapid drug design.

  • About
  • People
  • Projects
  • Publications
  • News
  • Contact

News

  • Phase 2 trial results April 22, 2022
  • TGA grants Provisional Determination to Vaxine for its COVID-19 Recombinant Protein Vaccine April 1, 2022
  • Efficacy of COVID-19 vaccines (Video) September 21, 2021
Read more

© 2022 Vaxine Pty Ltd. All rights reserved.
Made with ❤ by Howdy Innovation

